Trials / Terminated
TerminatedNCT01476111
Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer
A Prospective, Exploratory Observational Study Evaluating Specific Biomarkers in Primary Invasive Breast Cancer and Their Modulation by Standard Neoadjuvant Therapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 117 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine specific biomarkers in primary invasive breast cancer and explore their correlation with patient outcome following standard neoadjuvant treatment.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2011-11-22
- Last updated
- 2015-03-09
Locations
29 sites across 6 countries: United States, Belgium, Germany, Italy, Russia, United Kingdom
Source: ClinicalTrials.gov record NCT01476111. Inclusion in this directory is not an endorsement.